ABOUT THIS STUDY
- Histologically or cytologically confirmed, unresectable advanced renal cell carcinoma;
- Sunitinib as first-line treatment alone or combined with other therapies.
- History of Grade 3/4 severe allergic reaction to Sunitinib or its metabolites
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Toronto, Ontario
- Durham, North Carolina
- Heidelberg (Melbourne), Victoria